Simultaneous determination of 2-(p-chlorophenyl)pyrazolo[4,3-c] quinoline-3(5H)-one and its 6-, 7- and 8-hydroxy metabolites in plasma, urine and bile by high-performance liquid chromatography.
Kochak
G M
GM
Honc
F
F
Waldes
L
L
D000818:Animals; D014151:Anti-Anxiety Agents / Q000032:analysis* / Q000097:blood / Q000652:urine; D001646:Bile / Q000032:analysis; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D004355:Drug Stability; D006801:Humans; D011720:Pyrazoles / Q000032:analysis* / Q000097:blood / Q000378:metabolism / Q000652:urine; D051381:Rats
D014151:Anti-Anxiety Agents; D011720:Pyrazoles; C034704:2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3H)-one